Skip to main content
Skip to footer
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Reach out
Category:
News
Inflammatix collects $57M as it awaits FDA review of infectious disease test
September 12, 2024
Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million
September 12, 2024
Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up
January 2, 2024
Inflammatix sepsis test scores FDA breakthrough device designation
November 28, 2023
Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test
November 28, 2023
Your medical devices are getting smarter. Can the FDA keep them safe?
October 9, 2023
Point-of-care testing for infectious diseases in emergency settings
January 18, 2023
Do Your Genes Know What’s Making You Sick?
January 6, 2022
Artificial Intelligence for Clinical Decision Support in Sepsis
May 13, 2021
Inflammatix Checks off All the Right Boxes with Investors
March 19, 2021
←
1
2
3
4
5
…
8
→
September 12, 2024September 12, 2024January 2, 2024November 28, 2023November 28, 2023October 9, 2023January 18, 2023January 6, 2022May 13, 2021March 19, 2021
